iSpeak Blog

Vision for Biomanufacturing: Today’s Challenges and Tomorrow’s Therapies

Joseph C. Famulare
Vision for Biomanufacturing Banner

Biopharmaceutical manufacturing faces many new opportunities as we enter this decade. ISPE is returning to Boston for the 2020 ISPE Biopharmaceutical Manufacturing Conference on 1-3 June 2020, bringing you once again an innovative conference, followed by the 2020 ISPE Continuous Manufacturing Workshop and relevant training classes 4-5 June 2020. The Boston area, including Cambridge, is home to over 1,000 biotechnology companies, leading research, and academic institutions advancing biotechnology medicines.

2020 ISPE Biopharmaceutical Manufacturing Conference

This year, the 2020 ISPE Biopharmaceutical Manufacturing Conference will focus on advances in manufacturing, facilities, and analytics important to bring new therapies to patients. Now more than ever, manufacturing is on the critical path as many new treatments in the area of personalized medicines and individualized batch production present the challenge to bring these medicines through rapid development, reliable manufacturing, and availability to patients a pace with the advances clinical research is bringing to address unmet needs. At the same time, biosimilars are advancing with the opportunity to provide more access to medicines.

Topics that will be addressed at this conference include:

  • Production of monoclonal antibodies
  • Sterile fill finish operations and testing
  • Large volume and small batch production
  • Single use technology
  • Facility design
  • Construction and operation
  • Cell and gene therapy manufacturing and supply chain logistics
  • Evolution in analytical testing
  • Design and set up of laboratory operations

Session leaders and speakers are top leaders and experts in their fields of industry, regulatory, and/or academia. Topics will cover how we continually improve and manufacture our current processes, and continue to advance into new modalities. At the same time, the sessions will address how conventional norms of manufacturing testing and regulatory GMP and CMC oversight are advancing to meet patient needs.

Keep watching as our agenda advances, with updates from our planning committee. I look forward to seeing you in Boston in June.

View Agenda